Please Note: Froedtert Health has implemented a new security protocol which has resulted in the degradation of on-campus access to MCW Libraries' electronic resources. Users on the Froedtert network must sign in via OpenAthens when attempting to access electronic library resources (including UpToDate, VisualDx, etc.). MCW Libraries is aware of this change and is working to provide a permanent access solution. If you have MCW credentials, please sign in via MCW employees and students when prompted. If you are a Froedtert employee, click here to register for an OpenAthens account or view more information.
Medical College of Wisconsin COVID-19 Vaccine FAQ
For more information on the planning and distribution process identified by the Wisconsin Department of Health Services (DHS), view the COVID-19 vaccination plan DHS submitted to the Center for Disease Control and Prevention (CDC). The latest information on phase plans and vaccines allocated and administered in Wisconsin can be found on the DHS website.
The New England Journal of Medicine published the full text of the paper describing the study of the Pfizer-BioNTech vaccine, noting in the abstract, “The safety profile of BNT162b2 was characterized by short-term, mild-to-moderate pain at the injection site, fatigue, and headache. The incidence of serious adverse events was low and was similar in the vaccine and placebo groups.” It also highlighted that there was a 95% protection against COVID-19 in people age 16 or older.
Pfizer-BioNTech COVID-19 Vaccine - The Federal Drug Administration answers "Frequently Asked Questions" on the Pfizer-BioNTech vaccine
Moderna COVID-19 Vaccine - The Federal Drug Administration answers "Frequently Asked Questions" on the Moderna vaccine
Find information for COVID-19 vaccination on each specific vaccine as it becomes available.
Johnson & Johnson (Janssen) Phase 3 Clinical Trials are underway.
AstraZeneca COVID-19 Vaccine
Novavax COVID-19 Vaccine
MCW Libraries
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 955-8300